Home › Funds › ALKEME WEALTH, LLC › JNJ

ALKEME WEALTH, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

ALKEME WEALTH, LLC reported holding 23,614 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$6.3M, representing 2.36% of its reported portfolio and ranking #9 among its reported holdings. ALKEME WEALTH, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)23.61K sh
Reported value held$6.25M
Portfolio Weight2.36%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How ALKEME WEALTH, LLC's JNJ position evolved

ALKEME WEALTH, LLC first disclosed a stake in JNJ in Q3 2023 at 23,834 shares (US$3.7M). The position peaked in Q1 2026 at 25,925 shares, worth US$6.3M. Across 13 filings, ALKEME WEALTH, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 23,614 shares valued at US$6.3M — a reduction of -1,069 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 23.83K $3.71M New
Q4 2023 23.94K $3.87M Hold
Q1 2024 24.73K $3.77M Add
Q2 2024 25.08K $3.67M Add
Q3 2024 25.53K $4.14M Add
Q4 2024 24.10K $3.49M Reduce
Q1 2025 28.52K $4.73M Add
Q2 2025 28.47K $4.35M Hold
Q3 2025 27.69K $5.13M Reduce
Q4 2025 28.05K $5.81M Add
Q1 2026 25.93K $6.34M Reduce
Q2 2026 24.68K $6.27M Reduce
Q3 2026 23.61K $6.25M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has ALKEME WEALTH, LLC held JNJ?

ALKEME WEALTH, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ALKEME WEALTH, LLC's current position in JNJ?

As of Q3 2026, ALKEME WEALTH, LLC holds 23.61K shares of JNJ (JOHNSON & JOHNSON), valued at $6.25M, representing 2.36% of its reported portfolio and ranking #9.

Has ALKEME WEALTH, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), ALKEME WEALTH, LLC reduced its position in JNJ. The position peaked in Q1 2026 at 25.93K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.